Celsis introduces rapid microbial screening system for SMEs

The system enables quick product release, reducing manufacturing times and inventory requirements

Celsis, the global leader in rapid microbial testing systems for industry, has introduced the Celsis Accel system, a robust and easy-to-use rapid microbial screening system that helps small and medium-size manufacturing companies save time and money while releasing safe products to market.

Using proprietary reagent technology, the Celsis Accel system reduces the time needed for quality control (QC) assessment of microbial contamination. This shortens production cycle times by lowering quarantined inventory levels awaiting QC release and reduces working capital requirements. Faster QC results also provide an earlier indication of contamination allowing a faster and more effective investigation and corrective action, thereby reducing the economic impact of the event.

The Celsis Accel takes the robustness and ease-of-use of the widely adopted Celsis Advance platform packaged into a compact system specifically designed for small and medium-size manufacturing facilities. Easy-to-use, easy-to-learn software makes the system a great fit for busy microbiology labs in the beauty products and pharmaceutical sectors.

'Celsis works with product manufacturers of all sizes. Small and medium-size manufacturers have different testing requirements than large manufacturers and were asking for an instrument designed to meet their needs,' said Jay LeCoque, CEO. 'Responding to this demand, we developed the Accel for manufacturers whose testing requirements are smaller, but we employed the same robustness and ease-of-use of our popular large capacity Advance platform.'

To allow maximum flexibility with sample size and sensitivity, Celsis adapted the familiar sample tube platform to a precision movement carousel for easy loading and speedy processing with the ability to run 30 assays at a time. A fourth injector position gives the system flexibility to use new reagent technologies as they are developed. From reagent bottle access to sample loading, the ergonomic design puts everything easily at the fingertips of the user.

Celsis Accel.im takes advantage of software innovations, such as a new ribbon menu system, data security features, and the ability to export sample results. User administration features, an event log and more allow users full compliance with the FDA’s CFR 21 Part 11 and the EU’s Annex 11.